Global Wealth Management Investment Advisory Inc. Grows Stake in STERIS plc (NYSE:STE)

Global Wealth Management Investment Advisory Inc. grew its position in STERIS plc (NYSE:STE) by 122.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 500 shares of the medical equipment provider’s stock after purchasing an additional 275 shares during the quarter. Global Wealth Management Investment Advisory Inc.’s holdings in STERIS were worth $110,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. SG Americas Securities LLC grew its holdings in shares of STERIS by 66.5% during the third quarter. SG Americas Securities LLC now owns 4,085 shares of the medical equipment provider’s stock valued at $896,000 after buying an additional 1,632 shares during the last quarter. Exchange Traded Concepts LLC purchased a new stake in shares of STERIS during the third quarter valued at $54,000. Fjarde AP Fonden Fourth Swedish National Pension Fund grew its holdings in shares of STERIS by 16.8% during the third quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 21,562 shares of the medical equipment provider’s stock valued at $4,731,000 after buying an additional 3,100 shares during the last quarter. Cambridge Investment Research Advisors Inc. grew its holdings in shares of STERIS by 3.0% during the third quarter. Cambridge Investment Research Advisors Inc. now owns 7,537 shares of the medical equipment provider’s stock valued at $1,654,000 after buying an additional 220 shares during the last quarter. Finally, Robeco Institutional Asset Management B.V. grew its holdings in shares of STERIS by 286.3% during the third quarter. Robeco Institutional Asset Management B.V. now owns 761 shares of the medical equipment provider’s stock valued at $167,000 after buying an additional 564 shares during the last quarter. 94.69% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of brokerages have recently weighed in on STE. JMP Securities reissued a “market outperform” rating and set a $265.00 price objective on shares of STERIS in a report on Thursday, February 8th. Stephens reissued an “overweight” rating and set a $250.00 price objective on shares of STERIS in a report on Friday, February 9th. Needham & Company LLC reissued a “hold” rating on shares of STERIS in a report on Friday, April 12th. TheStreet raised shares of STERIS from a “c+” rating to a “b” rating in a report on Wednesday, February 7th. Finally, KeyCorp started coverage on shares of STERIS in a report on Tuesday, February 6th. They issued an “overweight” rating and a $253.00 price target on the stock. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat, STERIS has an average rating of “Moderate Buy” and a consensus price target of $239.60.

STERIS Price Performance

NYSE:STE opened at $205.04 on Thursday. STERIS plc has a one year low of $185.22 and a one year high of $254.00. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.49 and a current ratio of 2.43. The firm has a market cap of $20.26 billion, a price-to-earnings ratio of 35.91 and a beta of 0.81. The firm’s fifty day moving average is $219.61 and its two-hundred day moving average is $216.36.

STERIS (NYSE:STE) last issued its quarterly earnings data on Wednesday, February 7th. The medical equipment provider reported $2.22 earnings per share for the quarter, topping analysts’ consensus estimates of $2.17 by $0.05. The business had revenue of $1.40 billion during the quarter, compared to the consensus estimate of $1.35 billion. STERIS had a net margin of 10.48% and a return on equity of 13.67%. The company’s revenue was up 14.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.02 earnings per share. Research analysts expect that STERIS plc will post 8.67 EPS for the current year.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.